Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.34
-0.04 (-0.63%)
At close: Sep 5, 2025, 4:00 PM
6.27
-0.07 (-1.10%)
After-hours: Sep 5, 2025, 4:10 PM EDT

Coya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1059610712--
Market Cap Growth
4.26%-10.29%769.50%---
Enterprise Value
75659624--
Last Close Price
6.275.737.414.74--
PS Ratio
240.7226.9417.78---
PB Ratio
3.702.422.99-1.46--
P/TBV Ratio
3.702.422.99---
EV/Sales Ratio
177.3718.2015.97---
Debt / Equity Ratio
----1.54--
Asset Turnover
0.010.080.24---
Quick Ratio
6.6110.227.941.553.7819.51
Current Ratio
7.4311.598.151.883.9919.57
Return on Equity (ROE)
-63.99%-39.57%-58.64%--81.90%-
Return on Assets (ROA)
-38.53%-25.15%-18.53%-88.03%-44.96%-
Return on Capital (ROIC)
-44.48%-28.63%-22.88%-141.30%-50.96%-
Earnings Yield
-19.40%-15.54%-7.49%-99.77%--
FCF Yield
-15.71%-10.75%-10.48%-58.99%--
Buyback Yield / Dilution
-29.13%-49.93%-292.40%-0.01%-40.88%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q